Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The letters from the attorney to CM probably mentioned areas of prior art
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Change in order to facilitate the following.

<+ to generate a new basis of contracts with tpl/moore,

+ followed by revenue generation with professional support second,

+ pressure (stop of supply chain) to infringineers based on the ep730 in europe to follow,

+ supported with shareholder communication at best as possible.>

You need to add one more, IMHO. Distribution of earnings to shareholders as opposed to reinvestment. I think that is something Milestone prefers, as I do, and I think most everyone does.

Milestone, where are you? You OK?

Opty

7 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply